My research group develops non-traditional approaches to battle antibiotic-resistant bacteria, including silver nanoparticles and bacteriophages, and we investigate microbial pathogenesis in neurodegenerative diseases. Employing antimicrobial strategies can mitigate bacterial proteotoxicity.